Blueprint Medicines Corp (BPMC)

89.40 -2.22 (-2.42%) USD  |  NASDAQ  |  Dec 27, 16:00
89.46 +0.06 (+0.07%) After-Hours: 20:00
More

Blueprint Medicines Total Long Term Debt (Quarterly): 386.57M for Sept. 30, 2024

Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for BPMC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Debt Definition

View Total Long Term Debt Definition
Start Trial

Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Vertex Pharmaceuticals Inc 0.00
PTC Therapeutics Inc 285.11M
Biomarin Pharmaceutical Inc 594.63M
Regeneron Pharmaceuticals Inc 1.984B
SpringWorks Therapeutics Inc 0.00